Novo’s Metsera Bid Attracts FTC Scrutiny As Pfizer Matches $10B Offer
Pressure from the FTC and Pfizer is building around Novo Nordisk’s bid to snatch obesity biotech Metsera: The antitrust watchdog has spotted issues with the structure of Novo’s bid, while its New York-based rival has put more money on the table.
Novo’s Metsera Bid Attracts FTC Scrutiny As Pfizer Matches $10B Offer Read More »
